Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market baclofen tablets, 5 mg.
Baclofen is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease. It works by helping to relax the muscles. It will be manufactured at the group’s formulations manufacturing facility at Baddi.
The group now has 288 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.
Also read: Drug mfrs seek relaxation: Covid-19
